Abstract:Objective: To evaluate the effect of ovarian stimulation with rFSH+ rLH or rFSH+ LHcontaining gonadotropins(human menopausal gonadotropin,hMG) on IVF outcomes in the patients with lower than 1.2 mIU/ml serum LH.Methods: A total of 85 eligible women were enrolled in this study.As the conventional IVF treatment for tube-peritoneal factors,all patients were first undergoing luteal phase downregulation protocol,the rFSH was used for COH.Thirty-severn women with serum LH≥1.2 mIU/ml on COH day 6 were treated as the control(rFSH group),and went on using rFSH.Fourty-eight patients,with serum LH<1.2 mIU/ml,rolled into the experimental group,they were administered rFSH with exogenous LH [18 case for rLH(rLH group) and 30 cases for hMG(hMG group)].Results: Both rLH+rFSH or hMG+rFSH combination therapy achieved similar clinical outcomes compared with to rFSH group in terms of the dose of gonadotropins,days of COH,rate of 2PN,rate of good-quality embryos and clinical pregnancy rate.However,hMG group was significantly lower than that of rLH group(P<0.01).Conclusion: Both rLH+rFSH and hMG+rFSH administration in the patients with serum LH <1.2 mIU/ml on COH day 6 can achieve the same IVF clinical outcomes as rFSH group,hMG administration has advantages in reducing the doses of rFSH and therefore could reduce the costs for patients.

Effect of rLH or hMG Combined rFSH Administration during COH on IVF Outcomes in the Patients with Subnormal Serum LH